Replies to post #129292 on Biotech Values

[mcbio]

the earliest oral RA drug should be Rigel, followed by PFE's if I'm not mistaken.

PFE is further along and should be first. They've already reported Phase 3 data and the initial Phase 3 data for AZN/RIGL's fostamatinib won't be out until 2H12.